White label – Pompe disease - ClinicalTrials.eu

Study on the Safety and Effectiveness of Deucravacitinib for Patients with Active Discoid and/or Subacute Cutaneous Lupus Erythematosus

Not recruiting

2 1
Investigated Diseases:
Investigated Drugs:
- Deucravacitinib
Study on the Effectiveness and Safety of Sublingual Immunotherapy with Betula Pendula Pollen Extract for Patients with Birch Pollen Allergy

Not recruiting

4 1 1
Investigated Diseases:
- Rhinitis allergic
Investigated Drugs:
Study of IO102-IO103 and Pembrolizumab for Patients with Resectable Melanoma and Head and Neck Squamous Cell Carcinoma

Not recruiting

2 1 1 1
Investigated Diseases:
- Malignant melanoma
- Squamous cell carcinoma of head and neck
Investigated Drugs:
- Io103 Acetate
- Pembrolizumab
Study on Shortening Antibiotic Treatment for Febrile Neutropenia in Hematology Patients Using Cefepime and Drug Combination

Not recruiting

3 1 1 1
Investigated Diseases:
- Febrile neutropenia
Investigated Drugs:
Study on the Safety and Effectiveness of REGN7075 and Cemiplimab, with or without Chemotherapy, for Patients with Advanced Solid Tumors

Not recruiting

2 1 1 1
Investigated Diseases:
- Neoplasm malignant
Investigated Drugs:
Study on the Effects of Pegozafermin and Simvastatin for Patients with Severe High Triglycerides

Not recruiting

3 1 1
Investigated Diseases:
- Hypertriglyceridaemia
Investigated Drugs:
- Simvastatin
- Bio89-100
+5
Study on Long-term Safety of Linerixibat for Treating Itchy Skin in Patients with Primary Biliary Cholangitis

Not recruiting

3 1 1
Investigated Drugs:
- Linerixibat
+3
Study on Stopping Tocilizumab for Patients with Giant Cell Arteritis

Not recruiting

3 1 1 1
Investigated Diseases:
- Giant cell arteritis
Investigated Drugs:
- Tocilizumab
Study of Pembrolizumab and Chemotherapy for Patients with Newly Diagnosed Classical Hodgkin Lymphoma

Not recruiting

2 1 1 1
Investigated Diseases:
- Hodgkin’s disease
Investigated Drugs:
Study of Pembrolizumab, Belzutifan, and Lenvatinib for Patients with Advanced Clear Cell Renal Cell Carcinoma

Not recruiting

3 1 1 1
Investigated Drugs:
+8

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies